Skip to content

A Study on the Analgesic Efficacy and Safety of Transcutaneous Acupoint Electrical Stimulation in Patients Undergoing Single-Port Thoracoscopic Radical Lung Cancer Surgery

A Study on the Analgesic Efficacy and Safety of Transcutaneous Acupoint Electrical Stimulation in Patients Undergoing Single-Port Thoracoscopic Radical Lung Cancer Surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092998
Enrollment
Unknown
Registered
2024-11-27
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high-risk pulmonary nodules

Interventions

Low-intensity TEAS group:Low-intensity TEAS
Moderate-intensity TEAS group:Moderate-intensity TEAS
High-intensity TEAS group:High-intensity TEAS

Sponsors

The Third Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Ages 18-60, gender not limited. 2. Requiring single-port thoracoscopic surgery, with preoperative or intraoperative pathology indicating malignant lung tumor, without the need for conversion to two-port, three-port thoracoscopy or open thoracic surgery during the procedure. 3. All relevant preoperative auxiliary examinations have been completed. 4. Those classified as American Society of Anesthesiologists (ASA) Class I-II; 5. An informed consent form has been signed.

Exclusion criteria

Exclusion criteria: 1. Patients with chronic pain, a history of various neurological injury sequelae, and a history of psychiatric diseases are excluded. 2. Patients with local infection in the corresponding meridian, a history of surgery or the presence of scars; 3. Individuals with opioid addiction or dependence; 4. Patients with other malignancies at other sites.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale, VAS;

Secondary

MeasureTime frame
Comfort Score (BCS);Sleep Quality Score (PSQI);Analgesic Medication Usage;First Time to Get Out of Bed;Time to First Flatulence;Peripheral Plasma Levels of Beta-Endorphin, Enkephalin, and Dynorphin;Vital Signs Monitoring;Laboratory Test Results;Patient Satisfaction Score;

Countries

China

Contacts

Public ContactXuzhong Zhang

Rui'an People's Hospital

zxzdoctor@hotmail.com+86 138 6882 9090

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026